Podcasts about cancer screenings

Original Air Date: 10-18-2024Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Topic: New Clinical Developments - Recommended Colonoscopies, Cancer Screenings, Aspirin Intake, and MoreEmail the show: remedy@mpbonline.org. If you enjoy listening to this podcast, please consider contributing to MPB. https://donate.mpbfoundation.org/mspb/podcast. Hosted on Acast. See acast.com/privacy for more information.

In this Healthed lecture, the experts will answer questions about changes to the prostate cancer screening guidelines including the updated risk: benefit profile for PSA testing, who should have this test and how PSA test results should now be interpreted and managed. In addition, this case-based discussion will cover the practical application of the new draft guidelines on prostate cancer screening that are likely to be endorsed and become standard of care in the near future.See omnystudio.com/listener for privacy information.

Half of Americans skipped important cancer screenings in the past year. How does fear play a major factor? Or the amount of time we have? We spoke with Christopher Scuderi, DO, a primary-care physician and cancer survivor, about which screenings are most often missed, the risks of delaying them, screening guidelines to be aware of, and how to prioritize our health despite fear of knowing or busy schedules. He also highlights how talking with your doctor can help identify personal risk factors and the role healthy habits – like diet, exercise, sleep, and stress management – play in lowering cancer risk and supporting overall well-being.See omnystudio.com/listener for privacy information.

Lung cancer is one of the world's biggest killers. Today, we explore why, and how medical research into this disease is seeing the development of better diagnostic tools, cancer treatments and even a vaccine to prevent tumours from taking hold in the first place... Like this podcast? Please help us by supporting the Naked Scientists

340B savings do not just enable hospitals to provide more care, they also help hospitals pioneer innovative approaches to bringing care directly to patients. For West Virginia University Medicine, which serves a high population of Medicare and Medicaid patients, one of these 340B-funded innovations came from recognizing a need to increase cancer screening rates. WVU Medicine 340B Enterprise Director Karen Famoso tells us how the system's mobile cancer screening initiative came about.The Barriers to Cancer ScreeningWVU Medicine identified that some of the biggest social determinants of health for its West Virginia patients were relatively unique to the areas it serves. The rural state has significant travel barriers, small population areas, and high poverty rates, a combination that leaves thousands of patients without easy access to a source of primary care.Mobile Screenings Look for Breast, Lung CancersToday, WVU Medicine operates two types of mobile cancer projects: Bonnie's Bus and LUCAS. The former launched in 2009 and is a mobile mammography unit named after a patient who died because she had limited access to breast cancer screenings. Her family donated funding to the hospital to support this effort. More than a decade later, WVU Medicine introduced the mobile lung screening program LUCAS. That initiative provides low-dose CT scans to patients meeting the screening guideline using a nearly 70,000-pound tractor trailer.340B Is Key To Sustaining Mobile Screening EffortsFamoso says WVU Medicine funds its mobile cancer screening programs through grants and donations, but that is not enough to cover the full cost. That is where 340B savings can help cover the operating loss, which was almost $400,000 last year. Without those 340B savings, the health system's financial situation would not allow investments in mission-focused programs such as Bonnie's Bus and LUCAS.ResourcesLung Cancer Screening on WheelsHRSA Reviewing Rebate Pilot Proposals and CommentsSecond Federal Appeals Court Upholds State Contract Pharmacy Law

Send us a message with this link, we would love to hear from you. Standard message rates may apply.Colon cancer screening saves lives by catching cancer early and even preventing it, yet only 69% of eligible adults are up to date with their screenings. We explore who needs screening, what tests are available, and how to choose the right one for you.• Most adults should start colon cancer screening at age 45, even if healthy• Family history may mean you need to start screening earlier• Stool-based tests like FIT and Cologuard are convenient home options• Colonoscopy remains the gold standard, allowing doctors to remove polyps• One in 23 men and one in 25 women will develop colorectal cancer• The best screening test is the one you'll actually completePlease get screened! Check with your doctor about which test is right for you based on your risk factors and preferences.References1. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2). Qaseem A, Harrod CS, Crandall CJ, et al. Annals of Internal Medicine. 2023;176(8):1092-1100. doi:10.7326/M23-0779.2. AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review. Issaka RB, Chan AT, Gupta S. Gastroenterology. 2023;165(5):1280-1291. doi:10.1053/j.gastro.2023.06.033.3. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. Davidson KW, Barry MJ, Mangione CM, et al. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238.4. Colorectal Cancer Screening and Prevention. Sur DKC, Brown PC. American Family Physician. 2025;112(3):278-283.5. Increasing Incidence of Early-Onset Colorectal Cancer. Sinicrope FA. The New England Journal of Medicine. 2022;386(16):1547-1558. doi:10.1056/NEJMra2200869.6. From Guideline to Practice: New Shared Decision-Making Tools for Colorectal Cancer Screening From the American Cancer Society. Volk RJ, Leal VB, Jacobs LE, et al. CA: A Cancer Journal for Clinicians. 2018;68(4):246-249. doi:10.3322/caac.21459.7. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. JAMA. 2021;325(19):1978-1998. doi:10.1001/jama.2021.4417.8. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. Bibbins-Domingo K, Grossman DC, Curry SJ, et al. JAMA. 2016;315(23):2564-2575. doi:10.1001/jama.2016.5989.9. How Would You Screen This Patient for Colorectal Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Burns RB, Mangione CM, Weinberg DS, Kanjee Z. Annals of Internal Medicine. 2022;175(10):1452-1461. doi:10.7326/M22-1961.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Prostate cancer is one of the most urgent health issues facing men in Pennsylvania, according to cancer advocates and survivors who are working to remove barriers to early detection.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

When given appropriate information about mammogram screenings, including benefits, harms, and who should consider screening cessation, a cohort of older women largely made rational choices for themselves, a study by Nancy Schoenborn, a geriatrics expert at Johns Hopkins, has shown. … Information can help people decide to forgo cancer screening, Elizabeth Tracey reports Read More »

Just as there's a point in life when cancer screenings should begin, so too is there a point at which they can stop. That's usually because the likelihood that a cancer will kill you in the time you are likely … How might you feel about being told you can stop cancer screening? Elizabeth Tracey reports Read More »

Thoracic radiologists Jeffrey Kanne, Miranda Siemienowicz and Jonathan Chung discuss the current global status of lung cancer screening, offering tips and tricks for reading these studies. Meanwhile, Andrew and Frank talk about everything BUT pulmonary nodules: another shameful journal travesty, TB sniffer rats and ketamine epiphanies.   Lung cancer screening article ► https://radiopaedia.org/articles/lung-cancer-screening Retraction Watch - Tin Man Syndrome ► https://retractionwatch.com/2025/08/15/tin-man-syndrome-case-plagiarized-from-hoax-sleuths-say/ Those TB detecting rats ► https://apopo.org/what-we-do/detecting-tuberculosis Become a supporter ► https://radiopaedia.org/supporters Get an All-Access Pass ► https://radiopaedia.org/courses/all-access-course-pass Radiopaedia Community chat ► http://radiopaedia.org/chat Ideas and Feedback ► podcast@radiopaedia.org   The Reading Room is a radiology podcast intended primarily for radiologists, radiology registrars and residents. 

Researchers are utilizing the latest in artificial intelligence to see if it could be a key partner in helping to improve the speed, accuracy, and reliability of catching cancer early. Learn More: https://viewpointsradio.org/viewpoints-explained-the-race-to-improve-cancer-screening-and-detection Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Helen Stankiewicz Karita, Associate Professor at UCSF and a national expert on human papillomavirus (HPV)-related diseases in the anal canal, and National STD Curriculum Podcast Editor Dr. Meena Ramchandani discuss screening tools for anal dysplasia and anal cancer. View episode transcript and reference at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW), Program Director of the UW Infectious Diseases Fellowship Program, and Associate Editor of the National STD Curriculum.   

Innovation In Early Breast Cancer Detection To Enhance Health Equity.In this new episode of Narratives of Purpose's special series from the 2025 HIMSS European Health Conference, host Claire Murigande speaks with Alexander Antrobus, the CEO of Zedsen Ltd.Zedsen aims to bridge the gap in breast cancer screening accessibility and ensure that all women, irrespective of age or ethnicity, receive timely and effective diagnoses. Zedsen's approach involves developing a novel device, enabling more accurate detection of cancer. This innovation promises to make screening more accessible, affordable, and comfortable, particularly for younger women and those with high breast density, who are often overlooked in conventional screening paradigms. Be sure to visit our podcast website for the full episode transcript.LINKS:Learn more about Zedsen Ltd. at zedsen.com Follow Zedsen on social media: LinkedIn Connect with Alexander Antrobus: LinkedInFollow our host Dr. Claire Murigande: WEBSITE | LINKEDINFollow us: LinkedIn | Instagram Connect with us: narrativespodcast@gmail.com | subscribe to our news Tell us what you think: write a review This interview was recorded by Megan McCrory from the SwissCast Podcast Network. This series was produced with the support of Shawn Smith at Dripping in Black.CHAPTERS:00:02 - Need for Improvement in Early Breast Cancer Detection00:41 - Introducing Alexander and Zedsen Ltd.03:21 - The Zedsen Technology and its Application in Breast Cancer Screening05:27 - Alexander's Experience at the HIMSS Startup Pitchfest Competition06:52 - Breaking Breast Cancer Detection Barriers in Diverse Populations 11:14 - The Importance of Breast Cancer Awareness and Screening Innovations

Full article: CT Colonography for Colorectal Cancer Screening and Prevention: 20-Year Programmatic Experience at a U.S. Academic Medical Center CT colonography (CTC) serves as an important noninvasive test for colorectal cancer (CRC) screening, although its implementation has faced challenges. Jordan Kondo, MD, discusses the AJR article by Pickhardt et al. reporting one center's experience from 15,431 CTC examinations performed over a 20-year period.

Host: Brian P. McDonough, MD, FAAFP Guest: Mylynda Massart, MD, PhD Given its ability to identify universal cancer signals across multiple tumor types, multi-cancer early detection (MCED) testing is emerging as a promising tool to complement traditional, single-cancer screening methods. Joining Dr. Brian McDonough to share practical strategies for introducing MCED testing into clinical workflows and enhancing patient engagement is Dr. Mylynda Massart. Not only is she an Associate Professor at the University of Pittsburgh School of Medicine, but she's also the Founder and Medical Director of the Primary Care Precision Medicine Clinic and Associate Director of Clinical Services for the Institute for Precision Medicine at the University of Pittsburgh Medical Center.

Host: Brian P. McDonough, MD, FAAFP Guest: Marie Wood, MD Traditional cancer screening has always focused on individual organs, but now, multi-cancer early detection (MCED) tests are changing that paradigm. By analyzing multiple biomarkers through a single blood draw, MCED testing can detect signals from a variety of cancers—many of which currently lack effective screening tools. These multi-biomarker approaches not only outperform single-marker tests, but also demonstrate scientific rigor and clinical utility. Still, challenges remain, including false positives and integration with standard screening protocols. Joining Dr. Brian McDonough to explore the rationale for using a multi-biomarker approach to MCED testing is Dr. Marie Wood, Professor of Medicine at the University of Colorado School of Medicine and Medical Director of the Hereditary Cancer Program at the CU Cancer Center.

In this episode of Dental Unfiltered, Matt Brown and Dr. Andrew Vallo dive into the vital role of oral cancer screenings, with a focus on BioScreen technology. They discuss the importance of early detection, share personal experiences, and stress the need for dental practices to incorporate this service. The conversation underscores the cost-effectiveness and life-saving potential of offering these screenings in dental offices, aiming to enhance proactive patient care.

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from August 2-8, 2025.

Lung cancer remains one of the deadliest cancers in the United States, in part because it’s often detected too late. On The Spark, UPMC Thoracic Surgeon Dr. Troy Moritz joined the show to shed light on who should be screened, what symptoms not to ignore, and how technology is changing the way lung cancer is detected and treated. Who Should Be Screened? Dr. Moritz emphasized the importance of lung cancer screenings for a specific group:“We’re looking for people that are age 50 to up to 80 years of age and those people that have smoked what we consider to be 20 pack years,” he explained.That includes anyone who smoked a pack a day for 20 years — or an equivalent amount — and hasn’t quit within the last 15 years. These high-risk individuals are encouraged to undergo low-dose CT scans, which Dr. Moritz described as simple and noninvasive.“It’s pretty much just get in the CAT scan machine and buzz in, buzz out,” he said. “It’s not an MRI, so you don’t have to worry about that claustrophobic feeling.”Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Hurry—listen to Module 3 and claim your CME credit by August 19! Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. In this final module, Dr. Charles Vega, Clinical Professor of Family Medicine at the University of California, Irvine, explores the practical implementation of multicancer early detection (MCED) tests in clinical practice. Gain valuable insights into how these groundbreaking innovations could transform cancer screening and improve patient outcomes. Remember, you have only until August 19 to listen and claim your CME credit! Click here to claim your credit: bit.ly/4b9JU00 Click here to download the slide deck: bit.ly/40AkmoP

Don't miss your chance—listen to Module 1 and claim your CME credit by August 19! Join Dr. Charles Vega, a distinguished Clinical Professor of Family Medicine at the University of California, Irvine, as he explores the cutting-edge field of multicancer early detection (MCED). In this engaging session, Dr. Vega delves into the scientific foundations of blood-based cancer screening, examining both current limitations and the exciting promise of MCED technologies. Discover how these innovative tests use biomarkers to detect multiple cancers in a single, convenient screening—offering a breakthrough solution to challenges like low awareness and limited access to screening facilities. Remember, you have only until August 19 to listen and earn your CME credit! Click here to claim your credit: bit.ly/3X8apxa Click here to download the slide deck: bit.ly/4l0NTzc

Time is running out—listen to Module 2 and claim your CME credit by August 19! Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. In Module 2, Dr. Charles Vega takes you deeper into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases expected in 2024, early detection is more important than ever. Dr. Vega reviews the latest clinical trial data on MCED tests for gynecologic, gastrointestinal, and hematologic cancers, and explores how these advances could revolutionize cancer screening and improve patient outcomes. Don't forget—you must listen and claim your CME credit by August 19! Click here to claim your credit: bit.ly/41rS14I Click here to download the slide deck: bit.ly/4fdXwti

We catch up on three figures this week. First is Bari Weiss, who's trying to sell her upstart media org, The Free Press, to Skydance for a reported $250 million, just days after the network's merger with Paramount was approved and they said bye-bye to Stephen Colbert. Then we talk about RFK Jr's continued dismantling of our public health system, as well as an interesting lawsuit filed by the very nonprofit he founded. Finally, we look into Texas state representative and Presbyterian pastor-in-training, James Talarico, and discuss his viral moment on Joe Rogan. Show Notes Anti-vaccine group that Robert F. Kennedy Jr. founded files lawsuit against him over vaccine safety task force RFK Jr. to Oust Advisory Panel on Cancer Screenings, HIV Prevention Drugs Was Colbert Cancelled for Trump? Bari Weiss in Talks with Skydance for $250M Billionaires Back Anti-Woke “University.” James Talarico Delivers Sermon Against Christian Nationalism  James Talarico Questions Republican Bill Forcing Ten Commandments To Be Displayed In Classrooms  Joe Rogan Experience #2352 - James Talarico  Learn more about your ad choices. Visit megaphone.fm/adchoices

How can industry close the screening gap in breast cancer? Find out in this episode, where Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in imaging today. Together, Jade and Joana discuss her initial interest in a career in radiology, the pivotal role of professional societies in accelerating innovation, how AI is shaping the future of the field and much more. A little more on EMJ GOLD's guest… Dr Joana Reis was appointed Medical Affairs Breast Lead for radiology at Bayer in January of 2025. Before this, she was the Medical Affairs Lead for digital radiology at the company, where she developed strategies focusing on AI applications in imaging. Before joining Bayer, Joana worked as a Senior Consultant Breast Radiologist at Akershus University Hospital in Oslo, Norway.

The dark personality traits that underlie online political engagement; Parents' use of topical hormone preparations may pose unusual risks to their babies; Alternative to beta blockers for high blood pressure; Does lecithin lower cholesterol? Caloric restriction may extend life—but at what cost? A high-fiber diet may mimic caloric restriction's longevity benefits; Can mammograms cause cancer? 

An Ohio lawmaker has introduced the BEST Act to ensure coverage for supplemental screenings.

Australia's newest cancer screening program began a fortnight ago. It's looking to detect our nation's deadliest cancer – lung cancer. 

Have no fear! Lizz and Moji are BACK this week and bringing you a big beautiful breakdown of all the ways the Big Bullshit Bill is coming for our abortion rights, even when abortion isn't explicitly mentioned… because why not be as sneaky as possible, amirite? AND we spill the tea on this week's crop of anti-abortion schemes to ruin our reproductive lives.  GUEST ROLL CALL!FBK bestie Pamela Merritt, Executive Director of Medical Students for Choice, is in the house to talk about what demonizing DEI and closing rural hospitals means for med students and overall healthcare disparities. Spoiler alert: it ain't great. PLUS!! Here to lift our pro-abort spirits is none other than Iranian and Muslim political comedian and host of the Fake The Nation pod, Negin Farsad!! She yaps with us on what brings her joy, staying positive, and fighting TF back. You won't want to miss Negin lay out exactly what's got her boob sweat boiling these days! Scared? Got questions about the continued assault on your reproductive rights? THE FBK LINES ARE OPEN! Just call or text (201) 574-7402, leave your questions or concerns, and Lizz and Moji will pick a few to address on the pod! Times are heavy, but knowledge is power, y'all. We gotchu.  SAVE THE DATE: OPERATION SAVE ABORTION: Sign up for virtual 2025 OSA workshop on August 9th! You can still join the 10,000+ womb warriors fighting the patriarchy by listening to our past Operation Save Abortion pod series and Mifepristone Panel by clicking HERE for episodes, your toolkit, marching orders, and more. HOSTS:Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.socialMoji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.social SPECIAL GUESTS:Pamela Merritt IG/Threads: @PamelaMerritt_Sharkfu Bluesky: @Sharkfu.bsky.social Substack: @SharkfuNegin Farsad IG/TikTok/Patreon/Youtube: @NeginFarsad Bluesky: ‪@NeginFarsad.bsky.social‬ GUEST LINKS:Medical Students for Choice Website IG/TikTok: @MSFChoice Bluesky: @MSFChoice.bsky.social‬DONATE: Medical Students for ChoiceNegin Farsad WebsiteNegin Farsad LinktreeREAD: Negin's Column in The Progressive MagazinePODCAST: Fake the Nation NEWS DUMP:Texas Court Overturns Biden Administration's Expansion of Abortion PrivacyMan Goes in for a Vasectomy & This Is the Pamphlet He's GivenNew Book Confirms Trump Avoided Abortion Stance Because He Knew He'd LoseWith Trump's “One Big Beautiful Bill,” Congress Traded Your Pap Smear for a Billionaire's Tax BreakJudge Temporarily Blocks Trump Administration From Enforcing Funding Ban Against Planned ParenthoodExplaining Cost-Sharing Reductions and Silver Loading in ACA MarketplacesLISTEN: FBK Episode on Medina v Planned Parenthood Case EPISODE LINKS:TICKETS: Netroots Nations in New Orleans (use the code “BUZZKILLS” for 10% off)SIGN UP 8/9: (VIRTUAL) Operation Save Abortion at Netroots 2025 Our Amazing Moji in Nigeria6 DEGREES: The “Wednesday” Season 2, Part 1 TrailerJack Nicholson is Anti-AbortionBUY AAF MERCH!Operation Save AbortionSIGN: Repeal the Comstock ActEMAIL your abobo questions to The Feminist BuzzkillsAAF's Abortion-Themed Rage Playlist SHOULD I BE SCARED? Text or call us with the abortion news that is scaring you: (201) 574-7402 FOLLOW US:Listen to us ~ FBK Podcast Instagram ~ @AbortionFrontBluesky ~ @AbortionFrontTikTok ~ @AbortionFrontFacebook ~ @AbortionFrontYouTube ~ @AbortionAccessFront TALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE!PATREON HERE! Support our work, get exclusive merch and more! DONATE TO AAF HERE!ACTIVIST CALENDAR HERE!VOLUNTEER WITH US HERE!ADOPT-A-CLINIC HERE!EXPOSE FAKE CLINICS HERE!GET ABOBO PILLS FROM PLAN C PILLS HERE! When BS is poppin', we pop off!

Inilunsad ng pamahalaang nitong July 1 ang bagong screening program na layong matukoy ang mga kaso ng lung cancer nang mas maaga, lalo na sa mga taong may mataas na panganib, kabilang ang mga Indigenous Australians at ilang migranteng grupo.

In this heartfelt episode of Petworking, host Peter Kenseth interviews Dr. Tom Butera, CEO of Volition Veterinary, about their groundbreaking Nu.Q Cancer screening technology. Peter shares his personal experience with his dog Peony's melanoma diagnosis and how early detection saved her life.Dr. Butera, with his impressive background spanning academia, clinical practice, and corporate veterinary medicine, explains how Nu.Q is transforming early cancer detection in pets. This simple blood test can identify cancer biomarkers before symptoms appear, potentially saving millions of canine lives.With approximately 6 million dogs diagnosed with cancer annually in the US alone, this technology represents a paradigm shift in veterinary medicine - moving from treating symptomatic animals to early detection when immune systems are still strong.Learn about:How the Nu.Q test works and which cancers it detects bestWhen your dog should be screened (hint: all senior dogs, and predisposed breeds much earlier)The potential revolution in cancer treatment protocolsHow early detection can dramatically improve survival rates and quality of lifeThis episode offers invaluable information for every dog parent who wants to maximize their time with their beloved companion. Don't miss this important conversation about protecting your pet through early cancer detection!

A new national lung cancer screening program has been launched on 1 July which is aimed at detecting lung cancer in its early stages. In this SBS Hindi podcast, medical oncologist Dr Darshit A Thaker explains the key aspects of the program and shares important insights into lung cancer awareness, prevention and early detection.

Australians at higher risk of lung cancer are being urged to take advantage of a new screening program that has launched this month. The scan will be free for patients under Medicare bulk-billing through GPs, with eligibility to be determined by age - those between 50 and 70 - and smoking history. It is the first new national cancer screening program in nearly 20 years. Lung cancer is Australia's fifth most diagnosed cancer, but causes the greatest number of cancer deaths because it is often diagnosed too late. SBS's Biwa Kwan spoke with Anita Dessaix from the Cancer Council, about the at-risk groups the program is targeting; and the goal to prevent over 12,000 deaths over a decade

“The five-year relative survival rate for localized, or cancer that is confined to the colon or the rectum, is 91% for colon cancer and 90% for rectal cancer. Distant, metastasized to other organs—the five-year survival rate is 13% for colon and 18% for rectal cancer. So that really shows you the huge difference in screening and where screening can come in and make better outcomes,” ONS member Kris Mathey, DNP, APRN-CNP, AOCNP®, gastrointestinal medical oncology nurse practitioner at The James Cancer Hospital of The Ohio State University Wexner Medical Center, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about colorectal cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 4, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Leaners will report an increase in knowledge related to colorectal screening, early detection, and disparities. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episode: Episode 153: Metastatic Colorectal Cancer Has More Treatment Options Than Ever Before ONS Voice articles: AI-Assisted Colonoscopy Can Detect Small Colon Polyps As Colorectal Cancer Incidence Increases in Younger Patients, USPSTF Issues New Screening Guidelines. Here's How Nurses Can Encourage Uptake Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations Text Messaging Reduces Disparities in Colorectal Cancer Screening USPSTF Recommends Colorectal Cancer Screening Should Begin at 45 Clinical Journal of Oncology Nursing articles: Colorectal Cancer in Young Adults: Considerations for Oncology Nurses Colorectal Cancer Screening: A Quality Improvement Initiative Using a Bilingual Patient Navigator, Mobile Technology, and Fecal Immunochemical Testing to Engage Hispanic Adults Oncology Nursing Forum article: Disparities in Cancer Screening in Sexual and Gender Minority Populations: A Secondary Analysis of Behavioral Risk Factor Surveillance System Data ONS Course: Prevention, Detection, and the Science of Cancer—Oncology RN ONS Biomarker Database ONS Colorectal Cancer Learning Library American Cancer Society colorectal cancer resources Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Interestingly, recent studies suggest that starting screening even earlier than 45, such as age 40, could significantly reduce mortality and incidence rates, especially as colorectal cancer is rising among younger adults.” TS 2:42 “[Artificial intelligence]-enhanced screening tools are also being developed to improve sensitivity, reduce turnaround time, and enable real-time monitoring of disease progression. These innovations aim to make screening more accessible and accurate, especially in our underserved populations. So there's a huge impact on early detection.” TS 4:07 “Those with multiple chronic conditions or limited mobility may be less likely to complete screening, and those results may be harder to interpret. I mentioned a little bit earlier about our underserved or minority populations. Those barriers such as limited health literacy, lack of insurance, and cultural stigma can reduce screening uptake and ultimately follow-through.” TS 12:25 “Patient navigation programs—this is where we have trained navigators to help patients schedule appointments, understand procedures, and ultimately overcome some of these logistical hurdles. These have actually been shown to significantly boost screening rates. Also, those mailed stool-based-test kits—sending those kits directly to a patient home, especially with a personalized letter from a provider to add that extra little touch, has proven effective in increasing participation.” TS 21:29 “Our screening can detect cancer before symptoms appear and even identify precancerous polyps, which can be removed to prevent cancer altogether. Studies actually show that regular screening can reduce colorectal cancer mortality by up to 35% and the incidence of advanced-stage disease by nearly 30%. Just another reason why screening really does matter.” TS 25:53 “Evaluating our implicit bias, especially in something as critical as colorectal cancer, requires both introspection and instructional supports. One way of doing this is by auditing your practice patterns, really looking at reviewing your own screening recommendations and follow-up rates across different patient demographics. So are there certain groups that are less likely to be offered a colonoscopy? I think some of us may have an implicit bias—you see a patient; you're like, ‘There's no way they're going to agree to that, so I'm just not going to offer it.' Where we don't offer it, they don't have that opportunity to decline that. That can lead to further delay. And those patterns can reveal a bias in action.” TS 28:18

In this episode of "Coaching Healthcare Leaders," Dr. Alexander Itskovitch, medical director of the State Ser Cancer Center, shares his journey from aspiring surgeon to healthcare executive, highlighting the importance of mentorship, team empowerment, and work-life balance. He discusses leveraging artificial intelligence to enhance patient care and emphasizes the importance of fostering a positive organizational culture. The conversation addresses physician burnout and the need for supportive leadership. Dr. Alexander's insights offer valuable lessons on fostering resilient healthcare teams and enhancing patient outcomes through collaboration, innovation, and prioritizing staff well-being. Introduction to the Podcast and Guest (00:00:02) Dr. Lisa introduces the podcast, its mission, and welcomes Dr. Alexander, highlighting his background and achievements. Dr. Alexander's Career Journey (00:02:16) Dr. Alexander shares his early interest in surgery, training path, mentorship, and progression into leadership roles. Transition to Medical Director Role (00:04:51) Dr. Alexander discusses the pivotal decision to move into an administrative leadership position at a community cancer center. Training Required for Hepatobiliary Surgery (00:05:31) Explanation of the educational and training pathway to become a hepatobiliary surgeon, emphasizing mentorship and apprenticeship. Importance of Mentorship in Medicine (00:06:41) Discussion on the critical role of mentorship in medical training and ongoing professional development. A Day in the Life of a Medical Director (00:08:09) Dr. Alexander describes balancing clinical and administrative duties, weekly schedule, and responsibilities as a cancer center director. Impacting the Community Through Cancer Care (00:10:22) Exploration of how cancer screening, prevention, and high-risk programs benefit the local community. Challenges in Cancer Screening and Follow-Up (00:12:45) Addressing logistical and socioeconomic barriers to effective cancer screening and follow-up, and their impact on outcomes and costs. Information Overload and Integration in Healthcare (00:15:02) Challenges of managing vast medical information, the need for better integration, and the potential of AI to assist. Artificial Intelligence in Cancer Care (00:16:41) Examples of AI implementation to track incidental findings and improve patient safety and follow-up. Barriers to AI Adoption in Health Systems (00:18:28) Discussion on IT limitations, need for expertise, and bridging the gap between IT and clinical teams for AI adoption. Leadership and Team Management Philosophy (00:20:26) Dr. Alexander shares his leadership style, focus on culture, empowering team members, and hiring for fit and excellence. Empowering Teams and Achieving Success (00:23:10) Anecdotes about hiring strong team members, their impact on clinical trial enrollment, and the motivation derived from a great team. Work-Life Balance and Physician Well-being (00:24:19)- Strategies for Maintaining Personal Well-being, Setting Boundaries, and Encouraging Staff to Prioritize Self-Care. Leadership Responsibility and Staff Consideration (00:26:20) Emphasizes the leader's role in considering staff well-being, preventing burnout, and making thoughtful administrative decisions. Conclusion and Appreciation (00:27:15) Dr. Lisa thanks Dr. Alexander for sharing his journey and insights, closing the episode. Follow Dr. Itskovitch on LinkedIn

Dr. Joe Sirven and his team of medical experts discuss this month's biggest health headlines, from brain-eating amoebas to at-home test kits for cervical cancer.

If doctors can catch breast cancer early enough, the chances of survival are about 90%. In order to catch it early enough, women over the age of 40 usually get annual mammograms, paid for by their health insurance. Roughly half of those women have dense breast tissue that requires additional screenings, however, which aren't always covered by insurance. Also: a record-high stock market and the state of the economy surrounding the Strait of Hormuz.

If doctors can catch breast cancer early enough, the chances of survival are about 90%. In order to catch it early enough, women over the age of 40 usually get annual mammograms, paid for by their health insurance. Roughly half of those women have dense breast tissue that requires additional screenings, however, which aren't always covered by insurance. Also: a record-high stock market and the state of the economy surrounding the Strait of Hormuz.

- Overview of Cancer & the LGBTQI+ Community, Including HIV & HPV - The LGBTQI+ Community's Disproportionate Cancer Burden - Addressing the LGBTQI+ Health Disparities Gap, Including Mistrust of Health Care Providers - Barriers to Health Care Access, Including Discrimination - Health Care, Cancer Screening, Palliative & Supportive Care, Affordable Housing, Gay Men & Lesbian Cancer Issues - Transgender/Gender-Nonconforming People's Cancer Concerns - Challenges for LGBTQI+ Caregivers - Social Security Disability Benefits for LGBTQI+ People Living with Cancer - Military Service & the LGBTQI+ Community - Practical, Financial, Emotional & Social Concerns - Cancer Resources for the LGBTQI+ Community - Questions to Ask Our Panel of Experts

- Overview of Cancer & the LGBTQI+ Community, Including HIV & HPV - The LGBTQI+ Community's Disproportionate Cancer Burden - Addressing the LGBTQI+ Health Disparities Gap, Including Mistrust of Health Care Providers - Barriers to Health Care Access, Including Discrimination - Health Care, Cancer Screening, Palliative & Supportive Care, Affordable Housing, Gay Men & Lesbian Cancer Issues - Transgender/Gender-Nonconforming People's Cancer Concerns - Challenges for LGBTQI+ Caregivers - Social Security Disability Benefits for LGBTQI+ People Living with Cancer - Military Service & the LGBTQI+ Community - Practical, Financial, Emotional & Social Concerns - Cancer Resources for the LGBTQI+ Community - Questions to Ask Our Panel of Experts

- Overview of Cancer & the LGBTQI+ Community, Including HIV & HPV - The LGBTQI+ Community's Disproportionate Cancer Burden - Addressing the LGBTQI+ Health Disparities Gap, Including Mistrust of Health Care Providers - Barriers to Health Care Access, Including Discrimination - Health Care, Cancer Screening, Palliative & Supportive Care, Affordable Housing, Gay Men & Lesbian Cancer Issues - Transgender/Gender-Nonconforming People's Cancer Concerns - Challenges for LGBTQI+ Caregivers - Social Security Disability Benefits for LGBTQI+ People Living with Cancer - Military Service & the LGBTQI+ Community - Practical, Financial, Emotional & Social Concerns - Cancer Resources for the LGBTQI+ Community - Questions to Ask Our Panel of Experts

- Overview of Cancer & the LGBTQI+ Community, Including HIV & HPV - The LGBTQI+ Community's Disproportionate Cancer Burden - Addressing the LGBTQI+ Health Disparities Gap, Including Mistrust of Health Care Providers - Barriers to Health Care Access, Including Discrimination - Health Care, Cancer Screening, Palliative & Supportive Care, Affordable Housing, Gay Men & Lesbian Cancer Issues - Transgender/Gender-Nonconforming People's Cancer Concerns - Challenges for LGBTQI+ Caregivers - Social Security Disability Benefits for LGBTQI+ People Living with Cancer - Military Service & the LGBTQI+ Community - Practical, Financial, Emotional & Social Concerns - Cancer Resources for the LGBTQI+ Community - Questions to Ask Our Panel of Experts

Today we are joined by Dr Brandon Baraty and Associate Professor Viraj Kariyawasam, two leading experts in gastroenterology, to discuss the latest in inflammatory bowel disease (IBD) management and bowel cancer screening. They'll share insights into the most recent advancements in diagnostic techniques and cutting-edge treatment options shaping the future of patient care.This podcast is sponsored by Macquarie University Hospital, part of MQ Health - a trailblazer in healthcare, education and research.Dr Baraty is a senior Gastroenterologist, Hepatologist, and Endoscopist. He is the Head of Discipline of Gastroenterology at Macquarie University Hospital and the Director of Endoscopy at Ryde Hospital. Dr Baraty specialises in IBD care and is a leading expert in transabdominal ultrasound for IBD assessment in New South Wales.Associate Professor Kariyawasam is a Senior Gastroenterologist, Hepatologist, and Endoscopist at Macquarie University Hospital and Concord Hospital. He holds a PhD from Sydney University and has completed international fellowship training in IBD. He is dedicated to advancing IBD diagnosis and management while actively supporting patient advocacy and education.

Last month, former President Joe Biden announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are to screen for prostate cancer. Turns out, it's more complicated than it might seem. Host Ira Flatow is joined by oncologist Matthew Cooperberg and statistician Andrew Vickers, who studies prostate cancer screening, to help unpack those complexities.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Yankees offering free skin cancer screening To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Prostate cancer screening isn't just clinical—it's personal. Especially when headlines make it political.In this episode Tracy breaks down the buzz around President Joe Biden's recent prostate cancer diagnosis—and uses the moment to teach, clarify, and contextualize what it really means to screen for prostate cancer in 2025.As a former Urology PA, Tracy brings her clinical experience and clear communication to an often-misunderstood topic. She walks through:What the prostate does and how PSA testing worksWhat elevates PSA levels (that isn't cancer)Why BPH complicates the pictureWhat Gleason scores tell us about cancer aggressivenessCurrent USPSTF and AUA guidelines for prostate cancer screeningHow shared decision-making, not headlines, should guide patient careThis episode is a reminder to return to nuance and individualize care—especially when the world is watching.

The rhetoric and violence are both escalating on all sides in the Iran-Israel war. U.S. President Donald Trump is now demanding Iran's unconditional surrender, while appearing to threaten the country's supreme leader. Iran and Israel are firing missiles at each other. And Israeli Prime Minister Benjamin Netanyahu hints at regime change – in Iran.Also: Mark Carney is trying to make the most of what's left of the G7 in Alberta. The leaders kept their meetings going without the most consequential member: Trump. The U.S. president left last night – one day ahead of schedule. Even without him, leaders are focused on delivering more help to Ukraine and putting more pressure on Russia.And: New warnings about colorectal cancer. More young people are being diagnosed with it – and advocacy groups are calling for screening at a younger age.Plus: Indigenous groups protest the One Canadian Economy bill, 23andme fails to protect privacy, and more.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from May 31-June 6, 2025.

Hour 3 for 5/19/25 Drew discussed prostate cancer screening with Dr. Umang Gautam (1:00). Topics: frozen treatment (10:58), early testing (12:43), caller: cancer survivor (13:39), caller: my husband's health story (19:17), health foods (21:15), and caller: I had cancer (24:57). Then, Fr. Burke Masters discussed Pete Rose's Hall of Fame ban lifted (31:54). Topics: ethics in baseball (35:46), caller: I think he should be in the Hall of Fame (39:00), and caller: I think there is a lot of hypocrisy in sports (42:34), and morality in sports (45:46).

My guest is Dr. Mark Hyman, M.D., a physician and world leader in the field of functional medicine. We discuss a systems-based framework for diagnosing and treating the root causes of disease, rather than simply managing symptoms. We also cover cutting-edge health and longevity tools such as peptides, NAD/NMN, exosomes, proactive blood testing and cancer screening, as well as nutrition, supplementation, detoxification, and strategies for addressing specific diseases and health challenges. This discussion will benefit anyone seeking to improve their vitality or combat specific health concerns. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Joovv: https://joovv.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman ROKA: https://roka.com/huberman Timestamps 00:00:00 Dr. Mark Hyman 00:01:48 Functional Medicine, Chronic Fatigue Syndrome, Mercury; Systems Medicine 00:08:51 Metabolic Psychiatry; Medicine, Creating Health vs Treating Disease 00:12:19 Sponsors: Joovv & Eight Sleep 00:15:06 Wholistic View of Body, Root Causes 00:19:48 Medicine & Research; “Exposome”, Impediments & Ingredients for Health, Whole Foods 00:26:30 Seed Oils, Starch & Sugar, Ultra-Processed Foods; Obesity Rise 00:36:27 Sponsors: Function & ROKA 00:40:05 Tool: Ingredients for Health, Personalization; Multimodal Approach 00:46:25 Essential Supplements, Omega-3s, Vitamin D3, Multivitamin, Iodine, Methylated B12 00:56:54 Supplements & Traditional Medicine; Limited Budget & Nutrition 01:02:54 Air, Tool: Air Filters; Tap Water Filter; Tool: Health, Expense & Whole Foods 01:09:03 Food Industrialization, Processed Foods 01:14:23 Sponsor: AG1 01:16:18 Declining American Health & Nutrition, Politics, MAHA 01:26:03 Toxins, Food Additives, Generally Recognized As Safe (GRAS) 01:29:25 SNAP Program & Soda, Food Industry & Lobbying 01:36:58 Big Food, Company Consolidation, Nutrition Labels 01:44:21 GLP-1 Agonists, Doses, Risks; Food as Medicine, Ketogenic Diet 01:51:29 Cancer, Diets & Alcohol 01:54:03 Blood Markers, ApoB, Cholesterol, Tool: Test Don't Guess, Individualization 02:02:54 Mercury; Tool: Detoxification, Sulforaphane, N-Acetylcysteine (NAC) 02:04:56 Endocrine Disrupting Chemicals, Fertility, Tool: Hormone Panels; Heavy Metals 02:11:36 Upregulate Detox Pathways, Gut Cleanse, Tools: Cilantro Juice, Fiber 02:17:08 Peptides, PT-141 (Vyleesi), BPC-157, Thymosin Alpha-1; Risks, Cycling 02:22:03 Cancer Screening, Data & Personalized Health; Alzheimer's Disease 02:30:45 Longevity Switches, NAD, NMN; Exosomes, Stem Cells 02:39:50 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures